(Q26851863)

Pere Ginès

series ordinal

4

1 reference

language of work or name

1 reference

April 2015

1 reference

published in

Journal of Hepatology

1 reference

volume

62

1 reference

issue

1 Suppl

1 reference

page(s)

S131-43

1 reference

Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

The model for end-stage liver disease (MELD)

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Severe sepsis in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Acute-on-chronic liver failure: excellent outcomes after liver transplantation but high mortality on the wait list

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Pattern recognition receptors and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Patients with acute on chronic liver failure display "sepsis-like" immune paralysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: Possible role of Akt and IRAK-M

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Acute-on chronic liver failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Cellular therapy for liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective five-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Management of critically-ill cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Gene-specific control of inflammation by TLR-induced chromatin modifications

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Mesenchymal stem cells: a new therapeutic tool for AKI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Defining acute-on-chronic liver failure: will East and West ever meet?

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Toward an improved definition of acute-on-chronic liver failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Hyponatremia and mortality among patients on the liver-transplant waiting list

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

1 reference

7 January 2021

Severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Acute-on-chronic liver failure: extracorporeal liver assist devices

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Protein array technology to investigate cytokine production by monocytes from patients with advanced alcoholic cirrhosis: An ex vivo pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Disease tolerance as a defense strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Acute-on-chronic liver failure: pathophysiological basis of therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Retracted: Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Use of bone mesenchymal stem cells to treat rats with acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Effects of coencapsulation of hepatocytes with adipose-derived stem cells in the treatment of rats with acute-on-chronic liver failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.11.045

7 January 2021

10.1016/J.JHEP.2014.11.045

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

25920082

1 reference

Consolidated OpenCitations Corpus – April 2017